Scentre Group
ASX:SCG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Scentre Group
ASX:SCG
|
AU |
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
|
National Bankshares Inc
NASDAQ:NKSH
|
US |
|
Isetan Mitsukoshi Holdings Ltd
F:4HP
|
JP |
|
T
|
Texas Pacific Land Corp
F:9WY
|
US |
|
B
|
Bandai Namco Holdings Inc
XMUN:N9B
|
JP |
Wall St Price Targets
SCG Price Targets Summary
Scentre Group
According to Wall Street analysts, the average 1-year price target for SCG is 4.052 AUD with a low forecast of 3.262 AUD and a high forecast of 4.83 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SCG's stock price target?
Price Target
4.052
AUD
According to Wall Street analysts, the average 1-year price target for SCG is 4.052 AUD with a low forecast of 3.262 AUD and a high forecast of 4.83 AUD.
What is the Revenue forecast for Scentre Group?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 4 years is -3%.
What is the Operating Income forecast for Scentre Group?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 4%.
What is the Net Income forecast for Scentre Group?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is -2%.
